BNP Paribas Financial Markets’s Safeguard Scientifics, Inc. SFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-155
| Closed | -$809 | – | 4302 |
|
|
2022
Q1 | $809 | Hold |
155
| – | – | ﹤0.01% | 3981 |
|
|
2021
Q4 | $1.14K | Sell |
155
-169
| -52% | -$1.32K | ﹤0.01% | 4045 |
|
|
2021
Q3 | $2.88K | Hold |
324
| – | – | ﹤0.01% | 3754 |
|
|
2021
Q2 | $2.51K | Sell |
324
-8,139
| -96% | -$55.5K | ﹤0.01% | 3859 |
|
|
2021
Q1 | $57.7K | Buy |
8,463
+3,074
| +57% | +$22.3K | ﹤0.01% | 3569 |
|
|
2020
Q4 | $34.4K | Buy |
5,389
+277
| +5% | +$1.73K | ﹤0.01% | 3704 |
|
|
2020
Q3 | $28K | Buy |
5,112
+4,298
| +528% | +$25.7K | ﹤0.01% | 3713 |
|
|
2020
Q2 | $5.7K | Sell |
814
-5,247
| -87% | -$33.2K | ﹤0.01% | 3954 |
|
|
2020
Q1 | $33.6K | Buy |
6,061
+3,239
| +115% | +$28.9K | ﹤0.01% | 3731 |
|
|
2019
Q4 | $31K | Sell |
2,822
-302
| -10% | -$3.45K | ﹤0.01% | 3873 |
|
|
2019
Q3 | $35.4K | Sell |
3,124
-253
| -7% | -$3.02K | ﹤0.01% | 3665 |
|
|
2019
Q2 | $40.8K | Sell |
3,377
-656
| -16% | -$7.68K | ﹤0.01% | 3544 |
|
|
2019
Q1 | $43.8K | Buy |
4,033
+2,803
| +228% | +$28.4K | ﹤0.01% | 3580 |
|
|
2018
Q4 | $10.6K | Buy |
1,230
+188
| +18% | +$1.64K | ﹤0.01% | 3327 |
|
|
2018
Q3 | $9.74K | Buy |
1,042
+286
| +38% | +$3.11K | ﹤0.01% | 3745 |
|
|
2018
Q2 | $9.68K | Sell |
756
-4,007
| -84% | -$51.7K | ﹤0.01% | 3796 |
|
|
2018
Q1 | $58.3K | Sell |
4,763
-1,164
| -20% | -$14.2K | ﹤0.01% | 3482 |
|
|
2017
Q4 | $66.4K | Buy |
5,927
+3,924
| +196% | +$50.2K | ﹤0.01% | 3517 |
|
|
2017
Q3 | $26.7K | Sell |
2,003
-150
| -7% | -$1.85K | ﹤0.01% | 3447 |
|
|
2017
Q2 | $25.6K | Buy |
2,153
+2,088
| +3,212% | +$24.6K | ﹤0.01% | 3523 |
|
|
2017
Q1 | $826 | Sell |
65
-1,014
| -94% | -$12.8K | ﹤0.01% | 3744 |
|
|
2016
Q4 | $14.5K | Sell |
1,079
-316
| -23% | -$3.9K | ﹤0.01% | 3304 |
|
|
2016
Q3 | $18.1K | Buy |
1,395
+620
| +80% | +$8.22K | ﹤0.01% | 2949 |
|
|
2016
Q2 | $9.68K | Buy |
+775
| New | +$10.4K | ﹤0.01% | 2927 |
|
|
2016
Q1 | – | Sell |
-3,960
| Closed | -$57.5K | – | 3160 |
|
|
2015
Q4 | $57.5K | Sell |
3,960
-430
| -10% | -$6.94K | ﹤0.01% | 2713 |
|
|
2015
Q3 | $68.2K | Buy |
4,390
+2,667
| +155% | +$47.9K | ﹤0.01% | 2642 |
|
|
2015
Q2 | $33.5K | Buy |
1,723
+1,241
| +257% | +$22.8K | ﹤0.01% | 2725 |
|
|
2015
Q1 | $8.71K | Buy |
+482
| New | +$8.92K | ﹤0.01% | 2829 |
|
|
2014
Q4 | – | Sell |
-1,196
| Closed | -$22K | – | 3364 |
|
|
2014
Q3 | $22K | Buy |
1,196
+927
| +345% | +$18.3K | ﹤0.01% | 3111 |
|
|
2014
Q2 | $5.59K | Buy |
269
+128
| +91% | +$2.57K | ﹤0.01% | 2524 |
|
|
2014
Q1 | $2.96K | Sell |
141
-227
| -62% | -$4.51K | ﹤0.01% | 2544 |
|
|
2013
Q4 | $7.39K | Buy |
+368
| New | +$6.51K | ﹤0.01% | 2843 |
|
Other funds holding SFE
CCM
YCM
AC
CM
MAP
CP
BNP Paribas Financial Markets's SFE Position: Q2 2022 in Review
BNP Paribas Financial Markets sold out of Safeguard Scientifics, Inc. (SFE) in Q2 2022, closing a stake of 155 shares — an estimated $809 sold.
BNP Paribas Financial Markets first reported a position in SFE in Q4 2013 and held it in 32 quarters. The position peaked at $68.2K in Q3 2015. 48 funds tracked by Wall St. Rank hold SFE as of Q2 2022.
- BNP Paribas Financial Markets reported no remaining Safeguard Scientifics, Inc. position as of Q2 2022 after selling out during the quarter.
- BNP Paribas Financial Markets sold 155 Safeguard Scientifics, Inc. shares in Q2 2022, an estimated $809.
- BNP Paribas Financial Markets first reported a position in Safeguard Scientifics, Inc. in Q4 2013 and held it in 32 quarters.
- BNP Paribas Financial Markets's Safeguard Scientifics, Inc. position peaked at $68.2K in Q3 2015.
- 48 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q2 2022.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2022, filed 12 Aug 2022.